MEI Pharma Inc (MEIP)
3.06
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 10:21
MEI Pharma Net Income (Annual): 17.78M for June 30, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.78M |
| June 30, 2023 | -31.84M |
| June 30, 2022 | -54.45M |
| June 30, 2021 | -41.31M |
| June 30, 2020 | -47.17M |
| June 30, 2019 | -16.82M |
| June 30, 2018 | -40.07M |
| June 30, 2017 | 2.67M |
| June 30, 2016 | -20.86M |
| June 30, 2015 | -32.69M |
| June 30, 2014 | -27.15M |
| June 30, 2013 | -11.19M |
| Date | Value |
|---|---|
| June 30, 2012 | -7.523M |
| June 30, 2011 | -6.781M |
| June 30, 2010 | -7.896M |
| June 30, 2009 | -11.18M |
| June 30, 2008 | -12.41M |
| June 30, 2007 | -13.82M |
| June 30, 2006 | -7.386M |
| June 30, 2005 | -6.421M |
| June 30, 2004 | -8.538M |
| June 30, 2003 | -3.033M |
| June 30, 2002 | -0.123M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-54.45M
Minimum
2022
17.78M
Maximum
2024
-31.40M
Average
-41.31M
Median
2021
Net Income (Annual) Benchmarks
| Avid Bioservices Inc | -140.75M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -29.74M |
| iBio Inc | -24.91M |
| Theriva Biologics Inc | -18.35M |